Gerard Platenburg, PhD

Chief Scientific Officer at ProQR Therapeutics

Speaker

Gerard is co-founder of ProQR and served as Chief Scientific Officer since 2022, following his tenure as Chief Innovation Officer from 2014 to 2022. Gerard joined the ProQR board as executive director in May 2024. With an extensive background in RNA modulation and orphan drug discovery and development, Gerard currently leads R&D activities at ProQR.

Prior to joining our ProQR, Gerard worked at Isa Pharmaceuticals B.V. as its Chief Executive Officer. Gerard co-founded Prosensa Holding N.V., growing it to become a well-known clinical stage RNA modulation company, and held various positions during his tenure including as its Chief Executive Officer and Chief Development Officer. Gerard also worked at Pharming B.V.

Gerard is a passionate and driven pioneer of early-stage technologies. He holds a Master’s degree in Chemistry and Molecular Biology from Leiden University.